SRTCX1002 is a potent SIRT1 activator (STAC) that suppresses inflammatory responses by promoting p65 deacetylation and inhibiting NF-κB activity; it inhibits stimulus-induced NF-κB transcriptional activation and LPS-induced TNFα secretion with IC50 values of 0.71 µM and 7.58 µM, respectively.